Pono ka nui o nā buffers i ke kaʻina hana hoʻomaʻemaʻe ma hope o nā biopharmaceuticals. ʻO ka pololei a me ka hana hou ʻana o nā buffers he hopena nui ia i ke kaʻina hana hoʻomaʻemaʻe protein. Hiki i ka dilution pūnaewele a me ka ʻōnaehana dosing pūnaewele ke hoʻohui i nā ʻano buffers hoʻokahi ʻāpana. Hoʻohui ʻia ka wai makuahine a me ka diluent ma ka pūnaewele e loaʻa ai ka hopena pahuhopu. Hoʻokumu ʻia ka huahana ma ka ʻike ʻepekema, a loaʻa ka maikaʻi mai ka manaʻo o ka hoʻolālā (QbD). Ma o ka nānā ʻana a me ka kaohi ʻana o ka pūnaewele manawa maoli (Real in time) o nā ʻōkuhi kemika ʻelua, nā ʻano maikaʻi koʻikoʻi (CQA) o ka huahana (CQA), pH a me ka conductivity i ka wā o ke kaʻina hana, E hōʻoia e hāʻawi i nā buffers o ke ʻano paʻa a like no nā kaʻina hana ma hope e kōkua i nā kumu hoʻokuʻu parameter o nā ʻoihana biopharmaceutical. Pono ke kaʻina hana hoʻomākaukau wai kuʻuna i ka nui o nā pahu a me ka nui o ka nui. Lawe mai ʻo IVEN i nā mea kūʻai aku i kahi ʻike loea hou, e hōʻemi ana i ka wāwae o ka dosing buffer i ke kahua hana hoʻomaʻemaʻe, a e hōʻemi ana i nā kumukūʻai pre-investment a me post-production a me ka hana. , Hoʻomaikaʻi i ka pono hana, hōʻoia i nā ʻōnaehana kaʻina hana koʻikoʻi (CPP) o ka buffer a me kona traceability, a hoʻomaikaʻi hope i ka maikaʻi o nā lāʻau lapaʻau.